Tyrosine kinase inhibitors: new molecules in non-small cell lung cancer (EGFR AND ALK). ADMET and DMPK, [S. l.], v. 5, n. 1, p. 1–8, 2017. DOI: 10.5599/admet.5.1.352. Disponível em: https://pub.iapchem.org/ojs/index.php/admet/article/view/352. Acesso em: 14 nov. 2025.